Independent Health Group Limited

(Registration number: 05307845)
Balance Sheet as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	1,625,782	1,377,131
Current assets
Stocks	5	233,508	204,229
Debtors	6	1,475,459	1,827,522
Cash at bank and in hand		1,038,188	1,890,525
		2,747,155	3,922,276
Creditors: Amounts falling due within one year	7	(906,495)	(1,014,558)
Net current assets		1,840,660	2,907,718
Total assets less current liabilities		3,466,442	4,284,849
Creditors: Amounts falling due after more than one year	7	(407,621)	(362,454)
Provisions for liabilities		(139,953)	(85,204)
Net assets		2,918,868	3,837,191
Capital and reserves
Called up share capital	8	2	2
Retained earnings		2,918,866	3,837,189
Shareholders' funds		2,918,868	3,837,191

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Independent Health Group Limited

(Registration number: 05307845)
Balance Sheet as at 31 March 2025

Approved and authorised by the Board on 8 December 2025 and signed on its behalf by:

......................................... Dr M Wordsworth Director

Independent Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
8 The Office Village
Bath Business Park
Peasedown St. John
Bath
Somerset
BA2 8SG
England

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Independent Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Land & Buildings	2% straight line
Plant & Machinery	25% reducing balance
Motor Vehicles	25% reducing balance

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Independent Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 103 (2024 - 89).

Independent Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4	Tangible assets

	Land and buildings £	Furniture, fittings and equipment  £	Motor vehicles  £	Total £
Cost or valuation
At 1 April 2024	1,048,563	1,002,570	28,776	2,079,909
Additions	-	377,436	54,000	431,436
Disposals	-	(19,600)	-	(19,600)
At 31 March 2025	1,048,563	1,360,406	82,776	2,491,745
Depreciation
At 1 April 2024	12,247	682,438	8,093	702,778
Charge for the year	20,972	149,698	8,546	179,216
Eliminated on disposal	-	(16,031)	-	(16,031)
At 31 March 2025	33,219	816,105	16,639	865,963
Carrying amount
At 31 March 2025	1,015,344	544,301	66,137	1,625,782
At 31 March 2024	1,036,316	320,132	20,683	1,377,131

Included within the net book value of land and buildings above is £1,015,345 (2024 - £1,036,316) in respect of freehold land and buildings.
 

5

Stocks

	2025 £	2024 £
Other inventories	233,508	204,229

6

Debtors

Current	2025 £	2024 £
Trade debtors	1,323,385	1,033,222
Prepayments	68,463	57,568
Other debtors	83,611	736,732
	1,475,459	1,827,522

Independent Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

7

Creditors

	Note	2025 £	2024 £
Due within one year
Loans and borrowings	9	27,668	45,264
Trade creditors		183,777	301,212
Taxation and social security		133,265	369,735
Accruals and deferred income		535,293	264,034
Other creditors		26,492	34,313
		906,495	1,014,558

8	Share capital

Allotted, called up and fully paid shares

	2025		2024
	No.	£	No.	£
A Ordinary of each	1,000	1	1,000	1
B Ordinary of each	950	1	950	1
Ordinary of £1 each	-	-	-	-
	1,950	2	1,950	2

9	Loans and borrowings

Non-current loans and borrowings

	2025 £	2024 £
Bank borrowings	366,512	362,454
Hire purchase contracts	41,109	-
	407,621	362,454

Current loans and borrowings

	2025 £	2024 £
Bank borrowings	20,862	45,264
Hire purchase contracts	6,806	-
	27,668	45,264

Independent Health Group Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

10	Related party transactions

Transactions with directors

2025	At 1 April 2024 £	Repayments by director £	At 31 March 2025 £
Dr M Wordsworth
Overdrawn balance	653,119	(656,965)	(3,846)

2024	At 1 April 2023 £	Advances to director £	At 31 March 2024 £
Dr M Wordsworth
Overdrawn balance	257,077	396,042	653,119